American Well Corp. AMWL, -0.09%, known as Amwell, said late Wednesday that its upsized initial public offering priced at $18 a share, above the expected range of between $14 and $16 a share, as the Boston-based telemedicine …
Written by Tomi Kilgore
Sourced from Blueprint Medicines News Release
— GAVRETO, the only once-daily RET-targeted therapy, demonstrated durable efficacy, with complete responses in a subset of patients —
— Blueprint Medicines and Genentech will co-commercialize GAVRETO in the U.S. —
— FDA approval …
Written by Conor Hale
Two British companies are preparing to launch a simple COVID-19 saliva screening test that aims to provide an accurate result within 20 seconds—following its first uses at London’s Heathrow airport, one of the busiest in the …
Written by Conor Hale
To help meet the relentless demand for COVID-19 diagnostics, Thermo Fisher Scientific has stood up a new, $40 million manufacturing facility in six weeks.
The 120,000-square-foot plant at its Lenexa, Kansas site will be dedicated to …
Written by Nancy Crotti
The FDA has approved the Medtronic (NYSE:MDT) MiniMed 770G hybrid closed loop-diabetes management system for Type 1 diabetes patients aged 2 to 6 years.
The MiniMed 770G is the first-of-its-kind system that can automatically adjust …
